Background
==========

Interleukin-18 is a member of the IL-1 family of proteins that exerts proinflammatory effects and induces cartilage destruction *in vitro*.

Objective
=========

The goal of the present study was to investigate whether IL-18 mediates joint destruction *in vivo*, directly or via induction of other cytokines.

Results
=======

To this end, we performed both *in vitro* and *in vivo* kinetic studies. 35S-labeled explants of C57Bl/6 mice were cultured for 24 to 72 hours in either IGF-1, IGF-1/IL-18 or IGF-1/IL-1β in combination with or without IL-1 receptor antagonist (IL-1Ra) or an ICE inhibitor. Wild-type, TNFα-deficient and IL-1α,β-deficient mice were used for *in vivo* IL-18 exposure studies. Mice were injected intra-articularly with 10^7^ pfu mIL-18 adenovirus at day 0, and histopathology was examined at days 4, 7 and 14. *In vitro* IL-18 exposure for 24 or 48 hours did not induce cartilage degradation, determined as release of prelabeled proteoglycans. Cartilage degradation by IL-18 was only found after a 72-hour culture period. Blocking of IL-1 with IL-1Ra or ICE-inhibitor resulted in almost complete protection against IL-18 mediated cartilage degradation *in vitro*. Application of 10^7^ pfu AdmIL-18 resulted in prolonged elevated levels of IL-18, for up to 14 days. Histology at days 4, 7, and 14 revealed that local overexpression of IL-18 resulted in increasing joint inflammation and cartilage destruction in the wild-type mice. Of high interest, IL-18 gene transfer in IL-1α,β^-/-^ mice did not show cartilage damage at the various time points, although joint inflammation was similar to that in the wild-type animals. Overexpression of IL-18 in TNFα-deficient mice showed that TNFα was partly involved in IL-18-induced joint inflammation.

Conclusion
==========

Here we showed that IL-18 induces joint inflammation independently of IL-1. In addition, we showed that IL-1 generation, due to IL-18 exposure, was essential for marked cartilage degradation both *in vitro* and *in vivo*. These findings imply that IL-18 contributes, through separate pathways, to joint inflammation and cartilage destruction.
